| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $15,745,384 ) (Continued on the next page) |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 000 | 4 | NIH | 11/14/2023 | $427,500 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 000 | 1 | NIH | 7/19/2024 | $513,000 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 001 | 2 | NIH | 4/17/2024 | $24,127 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 1 | NIH | 1/5/2024 | $604,923 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 1 | NIH | 4/19/2024 | $46,694 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 001 | 1 | NIH | 4/19/2024 | $0 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 002 | 1 | NIH | 6/11/2024 | $1,280 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 1 | NIH | 1/23/2024 | $153,160 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA283463 | Mechanisms of DNA methylation signaling and dysregulation in colon cancer | 000 | 1 | NIH | 7/2/2024 | $632,319 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01DK139630 | Understanding putative beta-cell subtypes | 000 | 1 | NIH | 6/28/2024 | $698,646 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 3 | NIH | 12/4/2023 | $51,777 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS121371 | Motor cortical circuitry adaptations in experimental Parkinson's disease | 001 | 4 | NIH | 6/17/2024 | -$427,499 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS121371 | Motor cortical circuitry adaptations in experimental Parkinson's disease | 000 | 4 | NIH | 1/10/2024 | $427,500 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA268440 | High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader | 001 | 3 | NIH | 4/17/2024 | $21,732 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA268440 | High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader | 000 | 3 | NIH | 12/26/2023 | $391,163 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R03CA290259 | Dissecting the role of germline genetic variation and viral exposures as determinants of hematological disease predisposition | 000 | 1 | NIH | 6/28/2024 | $336,000 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 001 | 1 | NIH | 6/19/2024 | $0 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 000 | 1 | NIH | 6/19/2024 | $47,974 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA255506 | Discovery of small molecules targeting the histone acetylation reader ENL | 001 | 4 | NIH | 4/16/2024 | $21,520 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA255506 | Discovery of small molecules targeting the histone acetylation reader ENL | 000 | 4 | NIH | 11/13/2023 | $387,352 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21AI173758 | Mechanisms of histone crosstalk with bacterial pathogens | 001 | 2 | NIH | 5/10/2024 | $23,750 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21AI173758 | Mechanisms of histone crosstalk with bacterial pathogens | 000 | 2 | NIH | 10/30/2023 | $213,750 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA231466 | Molecular mechanisms of protein glycosylation and trafficking | 001 | 7 | NIH | 5/24/2024 | $451,250 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R56ES034765 | Molecular mechanisms underlying metabolic reprogramming by paternal benzene exposure | 000 | 1 | NIH | 4/19/2024 | $586,660 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 000 | 1 | NIH | 3/25/2024 | $796,798 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM151245 | Regulation of mitochondrial fatty acid synthesis in the control of mitochondrial metabolism. | 000 | 2 | NIH | 3/22/2024 | $427,500 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 000 | 2 | NIH | 4/25/2024 | $786,197 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG083568 | Endogenous retrovirus in joint aging and osteoarthritis development | 000 | 2 | NIH | 4/19/2024 | $610,479 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG077573 | Network and cellular vulnerability to pathological protein progression | 000 | 3 | NIH | 5/6/2024 | $441,969 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 3 | NIH | 2/21/2024 | $678,587 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165722 | Ketone Body Metabolism in CD8+ T Cell Responses | 000 | 3 | NIH | 5/1/2024 | $650,751 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01GM143308 | A NOVEL PROCESS SAFEGUARDS GENOME INTEGRITY IN THE MAMMALIAN GERM LINE | 000 | 3 | NIH | 5/8/2024 | $519,036 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS127292 | Molecular mechanisms for sorting lysosomal proteins | 000 | 3 | NIH | 5/17/2024 | $460,750 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K08DE031039 | Deciphering the Role of Frizzled Receptors in Palatal Development | 000 | 4 | NIH | 7/22/2024 | $109,274 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | T32CA251066 | Cancer Epigenetics Training (CET) Program | 000 | 4 | NIH | 6/17/2024 | $477,477 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR079174 | 5-methylcytosine oxidation in development and disease | 001 | 4 | NIH | 6/7/2024 | $29,260 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR079174 | 5-methylcytosine oxidation in development and disease | 000 | 4 | NIH | 3/27/2024 | $376,200 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K22CA272912 | Oncoprotein-regulated lineage plasticity in acute leukemia | 000 | 1 | NIH | 4/18/2024 | $192,240 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES031846 | Molecular Underpinnings in the Establishment of an Oncogenic 3D Genome inResponse to Environmental Arsenic Exposure | 000 | 5 | NIH | 3/1/2024 | $565,039 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS112363 | Structural and functional studies of CALHM channels | 001 | 5 | NIH | 6/4/2024 | $33,130 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS112363 | Structural and functional studies of CALHM channels | 000 | 5 | NIH | 2/15/2024 | $425,985 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG066764 | Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence. | 000 | 5 | NIH | 4/17/2024 | $597,032 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM138321 | Elucidating structures and molecular mechanisms of Pannexin channels | 000 | 5 | NIH | 6/5/2024 | $475,000 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R50CA243878 | Research Specialist Support- Establishing and Interpreting Abnormal DNA Methylation in Cancer | 000 | 6 | NIH | 7/22/2024 | $166,080 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS113894 | Epigenetic contributions to symptom asymmetry in Parkinson's disease | 000 | 5 | NIH | 4/5/2024 | $433,105 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS114409 | The contribution of the vermiform appendix to Parkinson's disease | 000 | 5 | NIH | 6/7/2024 | $435,728 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS117137 | Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat models | 000 | 5 | NIH | 6/7/2024 | $433,105 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM131754 | Structural mechanism of DNA replication | 000 | 6 | NIH | 5/21/2024 | $720,000 |
| 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 001 | 4 | NIH | 5/3/2024 | $33,250 |
|